Zai Lab and Novocure’s Optune Receive NMPA’s Innovative Medical Device Designation for its Tumor Treating Field Delivery System

Zai Lab and Novocure’s Optune Receive NMPA’s Innovative Medical Device Designation for its Tumor Treating Field Delivery System

Shots:

  • The designation allows Zai Lab to take advantage of an expedited approval procedure for Optune offering opportunities for pre-consultation with an input from the NMPA throughout the approval process
  • In Sept 2018, Zai Lab and Novocure signed an exclusive license agreement for Tumor Treating Fields, including the brand name Optune for Greater China. Additionally, in H2’18 Zai Lab has also launched the product in Hong Kong for treatment of glioblastoma (GBM)
  • Optune is a tumor treating delivery system that utilizes electric fields of specific frequencies to disrupt cancer cell division, inhibiting tumor growth and causing affected cancer cells to die and is marketed in the US, EU, Japan and certain other countries for the treatment of GBM  

Click here to­ read full press release/ article | Ref: Zai Lab| Image: Behance